EGFR and lung cancer: Among the subtypes of lung cancer, adenocarcinoma (a NSCLC) accounts for nearly 50% of cases generally associated with mutations in the kirsten rat sarcoma gene (KRAS), anaplastic lymphoma kinase gene (ALK), or epidermal growth factor receptor (EGFR) [3].